Core Insights - TOMI Environmental Solutions, Inc. has announced the adoption of its SteraMist ionized Hydrogen Peroxide (iHP) technology by a leading Cell and Gene Therapy (CGT) manufacturer for a commercial-scale facility, enhancing contamination control strategies to meet cGMP requirements [1][3] Company Overview - TOMI Environmental Solutions, Inc. is a global leader in decontamination and infection prevention, specializing in indoor surface disinfection through its Binary Ionization Technology® (BIT™) platform, which utilizes low percentage Hydrogen Peroxide to create a germ-killing aerosol [5][6] - The company provides solutions for a wide range of commercial structures, including hospitals, medical facilities, and various other environments [6] Industry Context - The rapid growth of the Cell and Gene Therapy sector is driving demand for advanced sterilization solutions, positioning TOMI at the forefront of this market shift [4] - As CGT manufacturers transition from development to commercial production, there is an increasing need for validated and scalable contamination control solutions, which TOMI aims to address with its comprehensive offerings [3][4]